Diprolene and Urticaria aggravated - a phase IV clinical study of FDA data

Summary:

Urticaria aggravated is reported as a side effect among people who take Diprolene (betamethasone dipropionate), especially for people who are female, 60+ old, also take Premarin, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Urticaria aggravated when taking Diprolene. It is created by eHealthMe based on reports of 1,043 people who have side effects when taking Diprolene from the FDA, and is updated regularly.

What is Diprolene?

Diprolene has active ingredients of betamethasone dipropionate. eHealthMe is studying from 1,048 Diprolene users. Check the latest studies of Diprolene.

What is Urticaria aggravated?

Urticaria aggravated (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,058 drugs and 723 conditions by eHealthMe. Check the latest studies of Urticaria aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

1,043 people reported to have side effects when taking Diprolene.
Among them, 12 people (1.15%) have Urticaria aggravated.

Could Diprolene cause Urticaria aggravated?

Among these 12 people:

What is the gender of people who have Urticaria aggravated when taking Diprolene? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Urticaria aggravated when taking Diprolene? *

What are other drugs people take besides Diprolene? *

What are other side effects people have besides Urticaria aggravated? *

Itching: 4 people, 33.33%
Swallowing Difficulty: 2 people, 16.67%
Rashes (redness): 2 people, 16.67%
Rash Erythematous (redness of the skin): 2 people, 16.67%
Face Oedema (swelling of face): 2 people, 16.67%
Feeling Hot: 2 people, 16.67%
Injection Site Erythema (redness at injection site): 1 person, 8.33%
Chest Pressure Sensation (feeling of pressure on chest): 1 person, 8.33%
Drug Hypersensitivity: 1 person, 8.33%
Dry Skin: 1 person, 8.33%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 2 people, 16.67%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 16.67%
Neurodermatitis (a skin disorder characterized by long lasting itching and scratching): 1 person, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Diprolene and have Urticaria aggravated?

- Check whether Urticaria aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diprolene:

Diprolene (1,048 reports)

Browse all side effects of Diprolene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urticaria aggravated:

Urticaria aggravated (2,058 drugs)

Browse all the conditions that are associated with Urticaria aggravated:

Urticaria aggravated (723 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on betamethasone dipropionate (the active ingredients of Diprolene) and Diprolene (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.